Immune Design (IMDZ) Announces Data Update for Lead Immunotherapy Programs Mar 12, 2018 08:04AM
Immune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Fol Mar 12, 2018 08:00AM
Immune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Fol Mar 12, 2018 08:00AM
Immune Design to Present at Upcoming Investor Conferences Feb 9, 2018 08:00AM
Immune Design to Present at Upcoming Investor Conferences Feb 9, 2018 08:00AM


Oct 25, 2017 05:40AM Immune Design (IMDZ) Prices 19.5M Share Common Offering at $4.10/Sh
Oct 24, 2017 08:14PM Immune Design Prices $80.0 Million Public Offering of Common Stock
Oct 23, 2017 04:16PM Immune Design (IMDZ) Announces 16M Share Common Offering
Oct 23, 2017 04:15PM Immune Design Announces Proposed Public Offering of Common Stock
Oct 17, 2017 01:12PM Immune Design (IMDZ) Trial Design Favorable, Maintains Outperform - Cowen
Feb 10, 2017 08:00AM Immune Design to Present at Upcoming Investor Conferences
Feb 29, 2016 08:00AM Immune Design to Present at Cowen and Company 36th Annual Health Care Conference
May 15, 2015 07:04AM Cowen Starts Immune Design (IMDZ) at Outperform
Apr 16, 2015 08:22AM Immune Design (IMDZ) 3M Common Stock Offering Prices at $26.50/Share
Apr 15, 2015 06:50PM Immune Design Prices Public Offering of Common Stock
Apr 15, 2015 06:50PM Immune Design Prices Public Offering of Common Stock
Feb 24, 2015 08:00AM Immune Design to Present at Upcoming Investment Conferences